RALOX or CAPOX + Bevacizumab in the First-line Treatment of Advanced CRC(ROCB Study)
Clinical trial NCT03813641 · UNKNOWN
Trial details
- NCT number
- NCT03813641
- Sponsor
- Shenzhen People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2021-02-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.